Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) ROCE % : 0.00% (As of Dec. 2021)

View and export this data going back to 2021. Start your Free Trial

What is Social Capital Suvretta Holdings III ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Social Capital Suvretta Holdings III's annualized ROCE % for the quarter that ended in Dec. 2021 was 0.00%.

Social Capital Suvretta Holdings III ROCE % Historical Data

The historical data trend for Social Capital Suvretta Holdings III's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Social Capital Suvretta Holdings III ROCE % Chart

Social Capital Suvretta Holdings III Annual Data

Trend

Dec21

ROCE %

Social Capital Suvretta Holdings III Semi-Annual Data
	Dec21
ROCE %	-

Social Capital Suvretta Holdings III ROCE % Calculation

Social Capital Suvretta Holdings III's annualized ROCE % for the fiscal year that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2021 )		(A: . 20 )		(A: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2021 )		(A: . 20 )		(A: Dec. 2021 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

Social Capital Suvretta Holdings III's ROCE % of for the quarter that ended in Dec. 2021 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2021 )		(Q: . 20 )		(Q: Dec. 2021 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2021 )		(Q: . 20 )		(Q: Dec. 2021 )
	=		/	( ( ( - )	+	( - ) )	/ )
	=		/	( (	+	)	/ )
	=		/
	=	%

(1) Note: The EBIT data used here is one times the annual (Dec. 2021) EBIT data.

Social Capital Suvretta Holdings III (NAS:DNAC) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Social Capital Suvretta Holdings III ROCE % Related Terms

Thank you for viewing the detailed overview of Social Capital Suvretta Holdings III's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Social Capital Suvretta Holdings III (Social Capital Suvretta Holdings III) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Social Capital Suvretta Holdings Corp III (NAS:DNAC) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

2850 W. Horizon Ridge Parkway, Suite 200, Henderson, NV, USA, 89052

Website

https://www.socialcapitalsuvrettaholdings.com

Social Capital Suvretta Holdings Corp III is a blank check company.

Executives

Jennifer A. Fox	director	C/O NUVATION BIO INC., 1500 BROADWAY, SUITE 1401, NEW YORK NY 10036
Sc Pipe Holdings Llc	10 percent owner	506 SANTA CRUZ AVE., SUITE 300, MENLO PARK CA 94025
Tolerantia, Llc	10 percent owner	110 EAST 59TH STREET, SUITE 3300, NEW YORK NY 10022
Jimenez Santos Jose Ignacio	director	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Deepak Jain	officer: Chief Operating Officer	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Darin J. Weber	officer: SVP of Regulatory Development	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Libbie Parker Mckenzie	officer: Chief Medical Officer	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
James Coulston	officer: Chief Financial Officer	C/O PROKIDNEY CORP., 3929 WESTPOINT BLVD., SUITE G, WINSTON-SALEM NC 27103
Sc Master Holdings, Llc	10 percent owner	506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025
Alan Lotvin	director	55 NOD ROAD, AVON CT 06001
Timothy Bertram	director, officer: Chief Executive Officer	C/O TENGION, INC., 2900 POTSHOP LANE, SUITE 100, EAST NORRITON PA 19403
Todd C Girolamo	officer: Chief Legal Officer	110 ALLEN ROAD, 2ND FLOOR, BASKING RIDGE NJ 07920
Uma Sinha	director	C/O EIDOS THERAPEUTICS, INC., 101 MONTGOMERY STREET, SUITE 2550, SAN FRANCISCO CA 94101
Control Empresarial De Capitales S.a. De C.v.	10 percent owner	INSURGENTES SUR #3500, PB, COL. PENA POBRE, DELEGACION TLALPAN, CP, MEXICO D.F. O5 14060
Pablo G. Legorreta	director, 10 percent owner	110 E 59TH STREET, SUITE 3300, NEW YORK NY 10022